GAG. N. Ablesimov

G. N. Ablesimov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


G. N. Ablesimov has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Nitrogen dioxide as a by-product of inhaled nitric monoxide therapy. Concentration in the inhaled gas mixture acceptable in clinical practice. A systematic review

    by A.E. Bautin, I.G. Chomakhashvili, K.YU. Afanasyeva, A.O. Marichev, A.M. Radovskiy, D.A. Kozyrev, E.K. Barygin, G.N. Ablesimov, N.V. Badalyan, M.S. Zhuravleva, et al.

    Objective: The study aimed to review the literature data on the recommended maximum concentrations of nitrogen dioxide during inhaled therapy with nitric oxide and to propose a general list of recommendations on safe therapy with inhaled nitric oxide. Methods: The systematic review was performed according to the PRISMA 2020 criteria. A search was carried out in databases Russian Science Citation Index, MedLine, Cochrane Library using the keywords “nitrogen dioxide”, “limit concentration”, “annual limit value”, “inhaled nitric oxide”. Results: The review included 28 articles, 20 sources from regulatory authorities setting hygiene standards, and 2 instructions for devices. Conclusion: For short periods of NO inhalation not exceeding one hour, the maximum permissible concentration of NO2 in the inhaled gas mixture may be defined as 5 ppm. In cases of NO inhalation not exceeding 24 hours, the maximum permissible concentration of NO2 in the inhaled mixture should be considered as 2 ppm. If the duration of NO inhalation exceeds 24 hours, the permissible concentration of NO2 in the inhaled gas mixture should be limited to 1 ppm. Received 29 November 2024. Revised 9 January 2025. Accepted 13 January 2025. FundingThis research was carried out within the state assignment “Development of a new device for supplying nitric oxide synthesized from atmospheric air into mechanical circulatory assist devices” No. 123021000129‑1. Conflict of interestThe authors declare no conflict of interest. Contribution of the authorsConception and study design: A.E. Bautin, A.A. Burov, Yu.V. ValuevaData collection and analysis: I.G. Chomakhashvili, K.Yu. Afanasyeva, D.A. Kozyrev, E.K. Barygin, G.N. Ablesimov, N.V. Badalyan, M.S. Zhuravleva, A.M. Pozhidaeva, A.A. Burov, Yu.V. ValuevaDrafting the article: I.G. Chomakhashvili, A.A. Burov, Yu.V. ValuevaCritical revision of the article: A.E. Bautin, A.O. Marichev, A.M. Radovskiy, A.A. BurovFinal approval of the version to be published: A.E. Bautin, I.G. Chomakhashvili, K.Yu. Afanasyeva, A.O. Marichev, A.M. Radovskiy, D.A. Kozyrev, E.K. Barygin, G.N. Ablesimov, N.V. Badalyan, M.S. Zhuravleva, A.M. Pozhidaeva, A.A. Burov, Yu.V. Valueva


  • Open Access

    Nitric oxide delivery into oxygenators of artificial and assisted blood circulation. Current state and prospects of technology development (literature review)

    by E. K. Barygin, A. O. Marichev, A. M. Radovskiy, V. V. Osovskikh, K. Yu. Afanasyeva, D. A. Kozyrev, I. G. Chomahashvili, G. N. Ablesimov, V. V. Pichugin, S. E. Domnin, et al.

    The use of cardiopulmonary bypass (CPB) technologies is often associated with ischemic and re-perfusion injury to the myocardium. The contact of patient’s blood with the surface of the extracorporeal circuit leads to platelets activation and often triggers a systemic inflammatory reaction. Nitric oxide (NO) is a signal molecule produced by the endothelium of blood vessels. Under normal circumstances, it prevents excessive activation and aggregation of platelets, thus providing an organ-protective effect. Currently, there is a considerable amount of data available about positive effects of use of inhaled NO. Nitric oxide delivery into oxygenators of artificial and assisted blood circulation. However, there is a limited amount of publications on effects of NO delivery into gas circuit of oxygenators of artificial and assisted blood circulation. The objective of this article was to summarize currently available information about effects of NO delivery into extracorporeal circuits oxygenators through extensive literature review.


  • Open Access

    Factors that determine cell-free hemoglobin concentration in blood prime during cardiac surgery with cardiopulmonary bypass: a prospective observational study

    by Андрей Евгеньевич Баутин, A. O. Marichev, L. I. Karpova, A. M. Radovskiy, E. K. Barygin, A. K. Gusenova, N. V. Blokhina, V. V. Osovskikh, G. N. Ablesimov, V. K. Grebennik, et al.

    INTRODUCTION: Plasma cell-free hemoglobin (Hbf) has a negative effect on the results of cardiac surgery. OBJECTIVE: Analysis of the dynamics of the Hbf during cardiosurgical operations with CPB. Identification of the main factors for increasing the Hbf. MATERIALS AND METHODS: A prospective, single-center, cohort study included 50 patients who underwent cardiac surgery with CPB. Hbf was monitored before surgery, during CPB (10 minutes after the start, then every 30 minutes) and every 6 hours for two days. RESULTS: An increase in Hbf levels was found in 90 % of surgical procedure. In 8 % of cases, hemolysis was mild (0.1 < Hbf ≤ 0.4 g/l), in 48 % — moderate (0.4 < Hbf < 1 g/l), severe (Hbf ≥ 1 g/l) was after 34 % of operations. After weaning from CPB Hbf rapidly decreases and after 12 hours drop to the preoperative level. Aortic cross-clamping is a risk factor with an odds ratio of 1.038 (p = 0.036). A positive correlation was established between the Hbf level and the duration of CPB (r = 0.76; p < 0.001). In ROC-analysis, a good predictive ability for development of severe hemolysis was demonstrated by the time of CPB: AUC 0.74 (p = 0.014) with a threshold value of 76 minutes. During CABG, severe hemolysis developed significantly less frequently than during valve corrections — 12.5 % versus 44.1 %, p = 0.026. Hbf content was significantly lower with an initial hemoglobin concentration < 140 g/l than in patients with an initial hemoglobin level ≥ 140 g/l — 0.7 (0.5; 0.95) g/l versus 0.9 (0.7; 1.28) g/l, p = 0.036. CONCLUSIONS: Hemolysis is typical for the cardiac surgeries with CPB. The time of aoral clamping and CPB, the type of surgcry, the hemoglobin content before surgcry have an impact on the severity of hemolysis.